diagnostics Archives - Blogs & Articles

Discussing “Laboratory miniaturization hand in hand with Microfabrication and Nanotechnology – systems integration at the microscale “with Dr. Vania Silverio of INESC-MN, Portugal.

February 22, 2021 MarketsandMarkets Conferences

Dr. Vania Silverio is a Microfluidics architect with strong background in microengineering. She combines know-how in simulation, design and fabrication of micron-sized fluidic paths with the integration of sensing and actuation elements towards the miniaturization of laboratories. Dr. Silverio is the Leader of the Microfluidics group at INESC Microsystems and Nanotechnologies (INESC MN) providing modular microfluidic solutions. She is Invited Assistant Professor at the Physics Department of Instituto Superior Tecnico (IST), ULisboa where, among others, she is the responsible for the curricular course on Microfluidics, unique in Portugal. She supervises…

Nicola Hodges from Royal United Hospitals Bath NHS Foundation, speaks about “Application of Point-Of-Care in disease outbreak”

February 10, 2021 MarketsandMarkets Conferences

Nicola is the POCT coordinator at the Royal United Hospitals Bath Foundation Trust and have been for just over 2 years now. She has been a senior biomedical scientist in biochemistry in the manual section again for around 2 years before this and a specialist BMS since 2003. Her most recent education was the certificate in expert practice in POCT awarded by the IBMS in 2021. She has always had a great passion for POCT, and she enjoys her job despite the many challenges. She believes that POCT is the…

Discussing ‘Reducing Errors at Point-Of-Care’ with Uchenna Okeahiala of Airedale and Bradford Hospitals Integrated Pathology Solutions, UK .

January 19, 2021 MarketsandMarkets Conferences

Graduated from University of Nigeria with a bachelor’s degree in Biomedical Sciences in 1989, Uchenna started her career as a Biomedical Scientist in Nigeria She relocated to the United Kingdom in 1991 where she obtained her Master’s degree in Biomedical Sciences from University of Cardiff with a Distinction in 1996 and went on to score a certificate in management from the Open University (1999). Later in 2006, she obtained a certificate in Extended Practice in Quality Management with Institute of Biomedical Sciences (IBMS). Since then has worked in various NHS…

Exclusive Speaker Interview with Richard Tedder – Speaker at the 2nd Annual MarketsandMarkets Infectious Diseases Diagnostics Conference

February 12, 2019February 12, 2019 MarketsandMarkets Conferences

London, UK. February 11, 2019 – MarketsandMarkets recently caught up with expert speaker Richard Tedder, Public Health England (PHE) – UK, regarding the conference 2nd Annual MarketsandMarkets Infectious Diseases Diagnostics Conference, taking place on 28th February – 1st March 2019 in Hotel Novotel London West, UK. Richard Tedder is a well know Virologist and Microbiologist and is head of the Blood Borne Viruses, National Infection Service, Public Health England – UK. He was also head of the Department of Virology at University College London. Mr. Tedder first published his work…

Everything about Fungal Infection – Types, Symptoms, Diagnosis and Treatment

February 11, 2019February 11, 2019 MarketsandMarkets Conferences

Fungal infection, most common among humans in the world. Probably everybody gets affected by fungal infection at some stage in life. It is common and is mostly caused due to the harmful fungi present in air, water, soil and plants. Fungal infection is not always dangerous but if it is left untreated or shows long-term consequences then it can get scary; but not if the infection is diagnosed and treated on time. In fact, meningitis and bloodstream fungal infections can be deadly. So, make sure, you do not delay in…

Neglected Tropical Disease may be Treated with the Help of Novel Drug

January 29, 2019January 31, 2019 MarketsandMarkets Conferences

A novel drug could be used to treat neglected tropical diseases developed by researchers which can prompt genuine inability and affect more than 157 million individuals globally. University of Liverpool – UK, to deliver the first novel completely manufactured and soundly structured anti-Wolbachia drug, AWZ1066S, could potentially be used to cure onchocerciasis and lymphatic filariasis (LF). Onchocerciasis are caused by the filarial worm transmitted by repeated bites of infected blackflies and LF occurs when filarial parasites are transmitted to humans through mosquitoes. Steve Ward, researcher at University of Liverpool said,…